Novel Cancer Therapy Developed From Basic Research Medical News Today Fri, 17 Feb 2006 9:03 PM PST Cancer researcher Professor Axel Ullrich, a director at the Max Planck Institute of Biochemistry in Martinsried, Germany, already showed at the beginning of the 1990s that blocking blood vessel development in a tumour slows down its growth, and shrinks its tissue. This fundamental principle led to the development of SUTENT®, whose active ingredient is Sunitinib... click link for more info. | | |
|
Technorati: FeedBlitz RSS Bloglet
Links to this post: